Skip to content

Surgical Treatment of Progressive Scoliosis With NEMOST Growing Rod

Evaluation of the Efficiency of Nemost Growing Spine Device Associated With Physiotherapy in the Surgical Treatment of Progressive Scoliosis of the Child

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02266667
Acronym
NEMOST
Enrollment
20
Registered
2014-10-17
Start date
2016-04-11
Completion date
2019-05-15
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive Scoliosis

Keywords

NEMOT device, pediatrics, surgery, progressive scoliosis

Brief summary

The purpose of this study is to evaluate the performance of the device NEMOST on maintaining of the correction of the scoliosis with growth preservation and avoiding iterative surgeries. Objective of this study is to evaluate the performance of the growing device NEMOST associated to physiotherapy at 12 months postoperatively in patients treated for progressive scoliosis and to evaluate its safety.

Detailed description

A number of scoliosis in the child remain progressive despite conservative treatment well conducted. Nowadays the most used treatment is early surgical treatment by the spinal instrumentation without graft called growing rods. The use of growing rods in patients with progressive scoliosis requires several repeated surgeries (every 6 to 12 months) in order to follow the growth of children. These repeated surgeries lead to a significant increased risk of complications, that's why many teams around the world have been seeking solutions which allow to obtain a rod expansion without repeated surgery. The purpose of our study is the evaluation of the use of medical device that will perform the correction of scoliosis and, at the same time, preserve the growth of the child's spine. In addition, the purpose of clinical investigation is to test the theory that distraction effort may be exercised without surgery thanks to traction manoeuvres and physiotherapy. This could allow to obtain in patients with progressive scoliosis, correction of spinal deformity while avoiding many repeated surgeries. Our reference device is growing rod NEMOST. When implanted, NEMOST rod is immediately turned on, for correcting and maintaining the correction of spinal deformity. After implantation, depending on development in Cobb angle, one or more elongations can be made by sliding the notched portion of the rod in its tunnel by a distraction effort (traction equipments and physiotherapy). Therefore, the growth device NEMOST will allow to continue, on request, the correction of spinal deformity by performing a distraction by external manoeuvres on the notched part without the need for surgery.

Interventions

DEVICE2 NEMOST rods : bilateral vertebral-pelvic implantation

Implantation of two NEMOST rods (bilateral vertebral-pelvic implantation)

DEVICE1 NEMOST rod :unilateral vertebral-pelvic implantation

Implantation of one NEMOST rod (unilateral vertebral-pelvic implantation)

Sponsors

Company EUROS
CollaboratorUNKNOWN
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Patient from 5 to 15 years old * Patient with neuromuscular scoliosis or progressive scoliosis resistant to conservative treatment * Patient with an indication of first-line surgery without graft * Patient with low skeletal maturity (Risser test = 0 and triradiate growth cartilages still open) * Signing of the consent by the holder (s) of parental authority and the investigator * Affiliated patient to a health service or entitled patient

Exclusion criteria

* Patient with a history of spinal surgery * Patient weighing more than 30 kg and with progressive scoliosis other than neuromuscular * Patient with contra-indication to Nemost device, that is to say: * Inflammation or acute Infection, local or systemic, * Allergy or intolerance titanium or polyetheretherketone, * Pathology or poor bone quality might compromise the attachment of the device, * Nonreducible Scoliosis, * Skin Substance insufficient to cover the wound, * Pathological Obesity, * Fracture and / or spinal tumor, * Patient whose behavior presents a risk of failure for the device.

Design outcomes

Primary

MeasureTime frameDescription
No surgical reoperation12 monthsThe lack of indication of surgical reoperations means that the correction of scoliosis is satisfactory and the growth had been maintained
No worsening of Cobb angle by more than 15 degrees since the initial correction12 monthsA worsening of the Cobb angle by more than 15 ° since the initial correction is considered an indication of reoperation

Secondary

MeasureTime frameDescription
reserve rod (mm)3 monthsThis amount reflects the actual elongation of the device
T1-T12 segment and T1-S1 segment3 monthswhich reflect the real growth of the spine
respiratory function6 monthsTranslated chest and lung growth, as well as the actual improvement of respiratory function
Cobb angle3 monthsRadiographic measure : less than 15 degrees since the initial correction
Safety of NEMOST3 monthsNature-incidence and severity of complications due to NEMOST : infections, elongation failure, problems with healing after surgery, neurological deficit) Nature and incidence of any medical and surgical intervention in relation to device NEMOST
Weight (kg)Every month for 18 monthsReflecting the improvement in the general and trophic status of the patient
Pelvic obliquity (mm)3 monthstranslated improving the overall balance of the trunk of the patient for the group of children with neuromuscular scoliosis
Cobb angle (degree)18 monthsRadiographic measure : less than 15 degrees since the initial correction

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026